The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine

About this Opportunity

Encourages and supports postdoctoral or clinical research fellows to conduct highly novel research in regenerative cancer medicine, directly relevant to enhancing the physiology of cancer survivors or mitigating the negative effects of cancer treatment using regenerative medicine approaches. The award covers the fellow's salary and benefits for mentored research; indirect costs are not permitted.

Who Can Apply

A doctoral degree (PhD, MD, MD/PhD or equivalent) in a related field.
A mentored postdoctoral or clinical research fellow position (or equivalent) at an academic, medical or research institution anywhere in the world.
Most recent doctoral degree or medical residency completed on or after 1 July 2022 (exceptions may be granted for up to 12 months of parental or justified personal or family leave).
At least 50% effort dedicated to the proposed project throughout the grant term.
Not eligible: anyone who is or has been at the rank of instructor, adjunct professor, assistant professor or higher.
No citizenship or geographic restrictions.
Active AACR membership in good standing by the submission deadline.
Not eligible: candidates for a further doctoral degree, employees or subcontractors of a US federal government entity or for-profit private industry, and holders of another AACR grant at the same time.
Eligibility is assessed at the start of the grant term (1 July 2027).

Ready to apply?

Apply Now

You will be taken to the funder's own website. Applications, guidelines and final eligibility decisions are managed by the funder, not by IVAN Research Institute.

Other Open Opportunities

The World Academy of Sciences (UNESCO): Research Continuity... TWAS-SISSA-Lincei Research Cooperation Visits Programme AACR-Lustgarten Foundation Career Development Award for Panc...

← Back to Grant Opportunities

At a Glance

Funder American Association for Cancer Research (AACR)

Status Open

Deadline 18 November 2026 Applications close at 1:00 PM US Eastern Time via ProposalCentral. Decision: February 2027; grant term starts 1 July 2027

Funding US$120,000 over 2 years

Thematic Area Regenerative cancer medicine; cancer survivorship

Apply Now